You are here: Industry Insights > Pfizer

News List

Pfizer to shut two manufacturing plants in India, putting 1700 jobs at risk firstwordpharma
January 10, 2019
Pfizer plans to shut down two plants in India that manufacture generic drugs due to falling demand, putting around 1700 jobs at risk. The company said it "has conducted a thorough evaluation of the...sites in India and concluded that due to the very signi
Pfizer to stop manufacturing operations in two units expressbpd
January 10, 2019
Both the plants located in Maharashtra and Tamil Nadu are export-oriented and came under Pfizer’s ownership after it acquired US-based drug maker Hospira in a $17-billion deal in February 2015
Pfizer partners with CytoReason on immune system models for drug discovery pharmaceutical-technology
January 09, 2019
Israeli-machine learning company CytoReason has announced it has signed a collaboration agreement with Pfizer in which the latter will leverage the former’s technology to create cell-based models of the immune system.....
Pfizer, Merck to terminate Phase III Bavencio study pharmatimes
January 04, 2019
Pfizer and Merck KGaA have announced that they will be terminating the Phase III JAVELIN Ovarian 100 study of Bavencio (avelumab), as the data did not support the study's initial hypothesis.
Independent DMC Recommends Trial Discontinuation of Staphylococcus aureus Vaccine americanpharmaceuticalreview
December 29, 2018
Pfizer announced the Phase 2b trial STRIVE (STaphylococcus aureus SuRgical Inpatient Vaccine Efficacy) evaluating the company’s investigational Staphylococcus aureus (S. aureus) multi-antigen vaccine (PF-06290510) is being discontinued due to futility....
Merck, Pfizer Terminate Avelumab Trial of Previously Untreated Advanced Ovarian Cancer americanpharmaceuticalreview
December 27, 2018
Merck and Pfizer have announced that data from a planned interim analysis of the Phase III JAVELIN Ovarian 100 study of avelumab did not support the study's initial hypothesis.....
Merck/Pfizer’s Bavencio flunks second ovarian cancer trial pharmaphorum
December 25, 2018
Merck KGaA and Pfizer PD-L1 inhibitor Bavencio has missed the mark in its second ovarian cancer trial in a month, this time failing in previously-untreated patients....
Pfizer’s CNS exit takes the form of a biotech spinout pharmaphorum
December 21, 2018
Pfizer’s plans to duck out of central nervous system R&D have come to fruition, with the creation of spinout biotech Cerevel Therapeutics.....
Astellas, Pfizer Announce Positive Top-Line Results from Xtandi Prostate Trial americanpharmaceuticalreview
December 21, 2018
Astellas Pharma and Pfizer announced the Phase 3 ARCHES trial evaluating Xtandi (enzalutamide) plus androgen deprivation therapy (ADT) in men with metastatic hormone-sensitive prostate cancer (mHSPC) met ....
GlaxoSmithKline, Pfizer to Form New Consumer Healthcare Joint Venture americanpharmaceuticalreview
December 21, 2018
GlaxoSmithKline has reached agreement with Pfizer to combine their consumer health businesses into a new Joint Venture, with combined sales of approximately $12.7 billion.....

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page